Mediterr J Rheumatol 2022;33(1):99-101
Clinical Phenotype and Mechanisms of Leukopenia/Neutropenia in Patients with Primary Sjögren’s Syndrome
Authors Information

Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

  1. Goules AV, Tzioufas AG. Primary Sjgren's syndrome: Clinical phenotypes, outcome and the development of biomarkers. Autoimmun Rev 2016;15(7):695-703.
  2. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000;29(5):296-304.
  3. Argyropoulou OD, Tzioufas AG. Update on Sjögren's Syndrome 2018. Mediterr J Rheumatol 2018;29(4):193-8.
  4. Mavragani CP, Moutsopoulos HM. Sjögren syndrome. CMAJ 2014;186(15):E579-86.
  5. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008;87(4):210-9.
  6. Schattner A, Friedman J, Klepfish A, Berrebi A. Immune cytopenias as the presenting finding in primary Sjögren's syndrome. QJM 2000;93(12):825-9.
  7. Brito-Zeron P, Kostov B, Solans R, Fraile G, Suarez-Cuervo C, Casanovas A, et al. Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann Rheum Dis 2016;75(2):348-55.
  8. Brito-Zeron P, Soria N, Munoz S, Bove A, Akasbi M, Belenguer R, et al. Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjögren's syndrome. Semin Arthritis Rheum 2009;38(5):389-95.
  9. Cafaro G, Gerli R, Bartoloni E. Association Between Glandular Infiltrate and Leukopenia in Sjögren Syndrome (SS): Data From the Italian Research Group on SS (GRISS). J Rheumatol 2020;47(12):1840-1.
  10. Coppo P, Sibilia J, Maloisel F, Schlageter MH, Voyer AL, Gouilleux-Gruart V, et al. Primary Sjögren's syndrome associated agranulocytosis: a benign disorder? Ann Rheum Dis 2003;62(5):476-8.
  11. Friedman J, Klepfish A, Miller EB, Ognenovski V, Ike RW, Schattner A. Agranulocytosis in Sjögren's syndrome: two case reports and analysis of 11 additional reported cases. Semin Arthritis Rheum 2002;31(5):338-45.
  12. Goules AV, Argyropoulou OD, Pezoulas VC, Chatzis L, Critselis E, Gandolfo S, et al. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development. Front Immunol 2020;11:594096.
  13. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009;88(5):284-93.
  14. Ismail F, Mahmoud A, Abdelhaleem H, Mamdoh A, Geneidy M, Kamal E. Primary Sjögren's syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia. Rheumatol Int 2013;33(4):1021-5.
  15. Wladis EJ, Kapila R, Chu DS. Idiopathic CD4+ lymphocytopenia and Sjögren syndrome. Arch Ophthalmol 2005;123(7):1012.
  16. Akhtari M, Curtis B, Waller EK. Autoimmune neutropenia in adults. Autoimmun Rev 2009;9(1):62-6.
  17. Sella R, Flomenblit L, Goldstein I, Kaplinsky C. Detection of anti-neutrophil antibodies in autoimmune neutropenia of infancy: a multicenter study. Isr Med Assoc J 2010;12(2):91-6.
  18. Matsuyama W, Yamamoto M, Higashimoto I, Oonakahara K, Watanabe M, Machida K, et al. TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood 2004;104(1):184-91.
  19. Verheugt FW, von dem Borne AE, van Noord-Bokhorst JC, Engelfriet CP. Autoimmune granulocytopenia: the detection of granulocyte autoantibodies with the immunofluorescence test. Br J Haematol 1978;39(3):339-50.